Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Cassava Sciences, Inc. (SAVA) and Encourages Shareholders to Learn More About the InvestigationAccesswire • 12/06/24
Cassava Sciences, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Cassava Sciences, Inc. (SAVA)Accesswire • 12/05/24
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Cassava Sciences, Inc. (SAVA) and Encourages Investors to Learn More About the InvestigationAccesswire • 12/05/24
ATTENTION Cassava Sciences, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your RightsAccesswire • 12/04/24
Cassava Sciences, Inc. (SAVA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the InvestigationAccesswire • 12/04/24
ATTENTION Cassava Sciences, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your RightsAccesswire • 12/03/24
Levi & Korsinsky Reminds Shareholders of an Investigation into Cassava Sciences, Inc. (SAVA) Regarding Potential Securities Fraud AllegationsAccesswire • 12/03/24
Bronstein, Gewirtz & Grossman, LLC Is Investigating Cassava Sciences, Inc. (SAVA) And Encourages Investors to ConnectAccesswire • 12/03/24
Bronstein, Gewirtz & Grossman, LLC Encourages Cassava Sciences, Inc. (SAVA) Stockholders to Inquire about Securities InvestigationAccesswire • 12/02/24
Shareholder Rights Advocates at Levi & Korsinsky Investigate Cassava Sciences, Inc. (SAVA) Regarding Possible Securities Fraud ViolationsAccesswire • 12/01/24
Cassava Sciences, Inc. Being Investigated on Behalf of Cassava Sciences, Inc. Investors. Contact Levi & Korsinsky For DetailsAccesswire • 11/29/24
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Cassava Sciences, Inc. (SAVA) And Encourages Investors to Reach OutAccesswire • 11/29/24
Cassava Sciences, Inc. Investigated by Shareholder Rights Advocates – Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - SAVAAccesswire • 11/28/24
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Cassava Sciences, Inc. (SAVA) And Encourages Stockholders to Reach OutAccesswire • 11/28/24
ATTENTION SAVA SHAREHOLDERS: Investors who Lost Money on Cassava Sciences, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing InvestigationAccesswire • 11/27/24
Bronstein, Gewirtz & Grossman, LLC Is Investigating Cassava Sciences, Inc. (SAVA) And Encourages Stockholders to ConnectAccesswire • 11/27/24
SAVA Stock Plunges 84% on Alzheimer's Drug Failure in Late-Stage StudyZacks Investment Research • 11/26/24
Down -83.93% in 4 Weeks, Here's Why You Should You Buy the Dip in Cassava Sciences (SAVA)Zacks Investment Research • 11/26/24
Cassava Sciences, Inc. (SAVA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the InvestigationAccesswire • 11/26/24
Cassava Sciences update: SAVA stock price collapses after much-criticized Alzheimer's drug flopsFast Company • 11/26/24
SAVA ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Cassava Sciences, Inc. Shareholders Who Lost MoneyAccesswire • 11/25/24
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Cassava Sciences, Inc. (SAVA) and Encourages Stockholders to Learn More About the InvestigationAccesswire • 11/25/24
'Pharma Bro' Martin Shkreli Tells Investors To 'Short SAVA,' Stock Falls Over 80% After Phase 3 UpdateBenzinga • 11/25/24
Cassava Sciences Plummets 84% After Embattled Alzheimer's Drug FlopsInvestors Business Daily • 11/25/24